Power3 Medical Products, Inc.
Power3 Medical Products, Inc., a development stage company, engages in commercializing its intellectual properties in the area of diagnosis and treatment of breast cancer, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, and Parkinson's disease. Power3 Medical Products, Inc. product candidates include BC-SeraPro, a blood serum protein breast cancer test for the diagnosis of breast cancer and to measure the quantitative expression level of 22 protein biomarkers in the serum that differentiate between breast cancer patients and control subjects. Power3 Medical Products, Inc. products also comprise NuroPro, a blood serum protein neurodegenerative disease diagnostic screening test for disease diagnostics, such as neurological diseases of motor control, such as Parkinson's disease, ALS, and similarly disorders; ALS specific tests for ALS vs. ALS-like disorders; Alzheimers disease specific tests; and a Parkinsons disease specific test. Power3 Medical Products has a joint venture agreement with NeoGenomics. Power3 Medical Products, Inc. was founded in 1992 and is based in The Woodlands, Texas.
Contact Details
Office Address
Power3 Medical Products, Inc.
3400 Research Forest Drive
The Woodlands, TX, USA 77381
Phone: (281) 466-1600
Fax: (281) 466-1481
Executives
Interim CEO, Interim CFO, and Director
Helen R. Park
President and Chief Scientific Officer
Ira L. Goldknopf
.webp)
.webp)
.webp)
.webp)
.webp)
